We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial

News   Oct 20, 2016

 
MorphoSys Receives Clinical Milestone for Start of Phase 1 Trial
 
 
 

RELATED ARTICLES

Colorectal Cancer Vaccine Proves Safe in Phase I Trial

News

A new colorectal cancer vaccine showed positive results in the phase 1 clinical trial to demonstrate that the approach is safe. The patients treated had no signs of serious adverse events and samples of their blood contained markers of immune activation – an early indication that the vaccine could activate immune cells to fight colorectal tumors and metastases.

READ MORE

Personalized Cancer Therapy Trial Shows Encouraging Results

News

A newly published study has demonstrated the potential of using transcriptomics to help get cancer patients on treatments they're most likely to benefit from.

READ MORE

Potential Hazards From Peanut Allergy Oral Therapy

News

Despite effectively inducing desensitization in the clinic, oral immunotherapy for peanut allergies appears to considerably increase allergic and anaphylactic reactions, compared with avoidance or placebo.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE